These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 29775268)

  • 1. [Discussion on Strengthening the Hospital Management of in Vitro Diagnostic Reagents].
    Gu Z; Chen W; Wang Y; Zhao M
    Zhongguo Yi Liao Qi Xie Za Zhi; 2016 May; 40(3):227-9. PubMed ID: 29775268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on administration of in-vitro diagnostic reagents].
    Wang Z; Qian H; Xu FL; Huang JH; Gu WK
    Zhongguo Yi Liao Qi Xie Za Zhi; 2005 Mar; 29(2):124-30. PubMed ID: 16011119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Discussion about Management of In Vitro Diagnostic Reagent].
    Huang L; Zhu J; Gu H; Geng Y
    Zhongguo Yi Liao Qi Xie Za Zhi; 2015 Mar; 39(3):232-4. PubMed ID: 26524796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical devices are everybody's business.
    Pilot LR
    Hospitals; 1977 Jun; 51(12):89-92. PubMed ID: 873456
    [No Abstract]   [Full Text] [Related]  

  • 5. Analyte-specific reagents.
    Press RD
    Mol Diagn; 1999 Mar; 4(1):71. PubMed ID: 10229777
    [No Abstract]   [Full Text] [Related]  

  • 6. [Refined Management of the Second Class Warehouse and Cost-benefit Analysis for In-vitro Diagnostic Reagent].
    Tang G; Hu L; Xu H; Fang Z
    Zhongguo Yi Liao Qi Xie Za Zhi; 2016; 40(4):308-10. PubMed ID: 29775534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Discussion on Regulatory Risk of in Vitro Diagnostic Reagents in Use].
    Li Z; Jiang H; Wang J; Shen J
    Zhongguo Yi Liao Qi Xie Za Zhi; 2018 Jan; 42(1):62-63. PubMed ID: 29862751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A pilot study on the quality management system of in-vitro diagnostic reagents].
    Liu X; Huang JH; Xu FL; Wang Z; Gu WK
    Zhongguo Yi Liao Qi Xie Za Zhi; 2006 May; 30(3):199-205. PubMed ID: 16929780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disclaimer now needed for analyte-specific reagents.
    Graziano C
    CAP Today; 1998 Nov; 12(11):5, 8, 11. PubMed ID: 10339306
    [No Abstract]   [Full Text] [Related]  

  • 10. Panel discussion: how to monitor and minimize variation and mistakes.
    Witte DL; Astion ML
    Clin Chem; 1997 May; 43(5):880-5. PubMed ID: 9166257
    [No Abstract]   [Full Text] [Related]  

  • 11. Medical devices; classification/reclassification; restricted devices; analyte specific reagents--FDA. Final rule.
    Fed Regist; 1997 Nov; 62(225):62243-60. PubMed ID: 10177056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analyte-specific reagents and the clinical laboratory.
    Tubbs RR; Abbott D
    Arch Pathol Lab Med; 1998 Jul; 122(7):585-6. PubMed ID: 9674540
    [No Abstract]   [Full Text] [Related]  

  • 13. Industry view on the regulation of ancillary reagents.
    Schifreen RS; Louth C
    Food Drug Law J; 1996; 51(1):155-9. PubMed ID: 11794348
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacogenomics. FDA puts the brakes on Roche's gene array test.
    Kaiser J
    Science; 2003 Nov; 302(5648):1134. PubMed ID: 14615505
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulation and evaluation of diagnostic products.
    Eavenson E
    Med Instrum; 1974; 8(1):59-62. PubMed ID: 4812344
    [No Abstract]   [Full Text] [Related]  

  • 16. [Practice of Refined Management of
    Huang Y; Tang G; Zhou Q
    Zhongguo Yi Liao Qi Xie Za Zhi; 2022 Mar; 46(2):230-232. PubMed ID: 35411757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Final chapter inked in IHC saga.
    Graziano C
    CAP Today; 1998 Jul; 12(7):1, 28, 32. PubMed ID: 10181877
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA regulation of analyte-specific reagents (ASRs). Implications for nucleic acid-based molecular testing.
    Garrett CT; Ferreira-Gonzalez A
    Diagn Mol Pathol; 1996 Sep; 5(3):151-3. PubMed ID: 8866226
    [No Abstract]   [Full Text] [Related]  

  • 19. [Research of regional medical consumables reagent logistics system in the modern hospital].
    Wu J; Zhang Y; Luo X; Zhang Q; Zhu J
    Zhongguo Yi Liao Qi Xie Za Zhi; 2013 Sep; 37(5):382-5. PubMed ID: 24409804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA's dual standards for biological indicators post threat.
    Dildine D
    HPN Hosp Purch News; 1981 Oct; 5(10):1, 13. PubMed ID: 10253825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.